Recommendation from Pharmaceuticals Sector Recommendation from Pharmaceuticals Sector The Indian pharmaceuticals industry plays a prominent role in the global pharmaceuticals arena. Ninad Ramdasi / Thursday, February 8, 2024 / Article rating: 5.0 This column gives you a scrip chosen by the research team during the fortnight that is fundamentally strong and expected to give good capital appreciation over a time period of 1 year.
Is The Pharmaceutical Industry Shaping Up To Be The New IT? Is The Pharmaceutical Industry Shaping Up To Be The New IT? US Drug Shortages and India’s Competitive Advantage Ninad Ramdasi / Thursday, September 7, 2023 / Article rating: 4.6 Given the shared traits between the pharmaceutical and IT industries,
Special Feature On Pharmaceutical & Healthcare Industry Special Feature On Pharmaceutical & Healthcare Industry Keeping Good Health Ninad Ramdasi / Thursday, June 15, 2023 / Article rating: 3.0 The corona virus pandemic drew everyone's attention to the need for basic medical facilities across the country, elevating the pharmaceutical and healthcare industries and compelling the government to pay greater attention to them. Mandar Wagh describes how being a major participant in terms of both volume and value globally, the government's emphasis and initiatives all contribute to the success of the industry
Advent International buys more than 50 per cent stake for Rs 6300 crore in this pharma company. Do you own it? Advent International buys more than 50 per cent stake for Rs 6300 crore in this pharma company. Do you own it? Advent is expected to buy 51 per cent of the promoter’s stake in the company and launch an open offer for an additional 26 per cent Bhavya Rathod / Monday, December 26, 2022 / Article rating: 4.3 The company released a press release on Monday, stating Advent International has entered into definitive agreement to acquire significant stake in the company and intends to explore the merger of its portfolio company
This pharma company received USDA approval for a generic drug which clocked over Rs 90 crore in sales, do you own it? This pharma company received USDA approval for a generic drug which clocked over Rs 90 crore in sales, do you own it? The company is ranked among the world’s top 100 biopharmaceutical companies and among the world’s top 50 companies in the off-patent sector. Bhavya Rathod / Monday, December 19, 2022 / Article rating: 4.4 Glenmark Pharmaceuticals Ltd is an innovation-driven global pharmaceutical company with a presence across Specialty, Generics and OTC businesses
This pharma company to acquire a franchise from Glenmark Pharmaceuticals for Rs 313.7 crore This pharma company to acquire a franchise from Glenmark Pharmaceuticals for Rs 313.7 crore Shares of the company surged more than 1.80 per cent. Praveenkumar Yadav / Thursday, December 15, 2022 / Article rating: 5.0 Shares of the company surged more than 1.80 per cent.
This pharma company stock went 8 per cent high, do you own it? This pharma company stock went 8 per cent high, do you own it? With its shares up 8 per cent, the Indian multinational pharmaceutical company posted a net profit of Rs 130 crore in the second quarter, while its turnover increased to Rs 4,145 crore. Kiran Shroff / Thursday, November 10, 2022 / Article rating: 5.0 This pharma company stock went 8 per cent high, do you own it? With its shares up 8 per cent, the Indian multinational pharmaceutical company posted a net profit of Rs 130 crore in the second quarter, while its turnover increased to Rs 4,145 crore.
Upcoming collaboration: Two leading pharma company stocks to watch out for Upcoming collaboration: Two leading pharma company stocks to watch out for US FDA approved a benzyl alcohol and propylene glycol-free formulation to minimize gasping syndrome risk, for the treatment of seizures in newborns Kiran Shroff / Wednesday, November 9, 2022 / Article rating: 4.5 Upcoming collaboration: Two leading pharma company stocks to watch out for US FDA approved a benzyl alcohol and propylene glycol-free formulation to minimize gasping syndrome risk, for the treatment of seizures in newborns.
Shilpa Medicare skyrockets by 10.47 per cent on a weak market day! Shilpa Medicare skyrockets by 10.47 per cent on a weak market day! The board of the company also has recommended a dividend of Rs 1.10 per equity share for the financial year ended March 31, 2022. Sayali Kotwal / Tuesday, May 24, 2022 / Article rating: 5.0 The shares of Shilpa Medicare soared 10.47 per cent to Rs 453.25 on BSE after the company announced promising results for the quarter that ended on March 31, 2022.
Multibagger Update: Fredun Pharmaceuticals locks at 5 per cent upper circuit; here's why! Multibagger Update: Fredun Pharmaceuticals locks at 5 per cent upper circuit; here's why! The pharma company announced the final dividend at 7 per cent per equity share, having a face value of Rs 10 each for the financial year 2021-22. Mandar Wagh / Tuesday, May 17, 2022 / Article rating: 4.7 The net profit of Fredun Pharmaceuticals soared 214.34 per cent to Rs 6.33 crore.
Market Wrap: Benchmark indices close higher while Broader indices outperformed! Market Wrap: Benchmark indices close higher while Broader indices outperformed! On April 25, 2024, foreign institutional investors (FII) offloaded shares worth Rs...
Rs 35,10,00,000 total order from Integral Coach Factory: This multibagger company bags... Rs 35,10,00,000 total order from Integral Coach Factory: This multibagger company bags... The stock gave multibagger returns of 125 per cent in just 1 year, 1,150 per cent in 3...
Heavy buying: Back-to-back upper circuit in this multibagger SME stock; Secures... Heavy buying: Back-to-back upper circuit in this multibagger SME stock; Secures... Shares of the company have gained about 340 per cent in the last one year.
Penny stock at Rs 9.43: This micro-cap company bags new order worth Rs R 2,94,65,496... Penny stock at Rs 9.43: This micro-cap company bags new order worth Rs R 2,94,65,496... The stock is up by 92 per cent from its 52-week low of Rs 4.91 per share.
3,350 per cent multibagger returns: This electric vehicle (EV) loan provider company... 3,350 per cent multibagger returns: This electric vehicle (EV) loan provider company... From Rs 3.93 per share to Rs 137.50 per share, the stock gave multibagger returns of...
Mastering Your Money: A comprehensive guide to portfolio management (Part 2) Mastering Your Money: A comprehensive guide to portfolio management (Part 2) Mastering your investments with portfolio management
Why an Interest Coverage Ratio of 3 is preferable over 2 for equity investors? Why an Interest Coverage Ratio of 3 is preferable over 2 for equity investors?
How do cricket tactics illuminate stock market strategy? How do cricket tactics illuminate stock market strategy?